ArticleJournal of chemical information and modeling2026
Ligand Drift Rate Descriptor in Receptor Pocket: Molecular Docking Sampling for Differentiating Partial Agonists in Nuclear Receptors.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The recent discovery that inverse agonists bind to a secondary orthosteric site in PPARγ reveals unexpected structural complexity in this nuclear receptor. To differentiate between full and partial agonists, we hypothesize that partial agonists exhibit dynamic positional behavior, moving among alternative binding sites at equilibrium when saturated, while full agonists bind directly and consistently to the primary orthosteric site. Using a two-state model derived from the Boltzmann distribution and molecular docking (MODO) sampling, we developed a computational metric called the Ligand Drift Rate (LDR) Descriptor to differentiate full agonists (Emax ≥ 90%) from partial agonists (Emax ≤ 45%) of PPARγ by simulating ligand positional instability within the primary orthosteric binding pocket. We combined molecular docking and hydrogen bond fluctuation analysis across 28 PPARγ-ligand complexes (18 full agonists and 10 partial agonists). MODO sampling was performed with several algorithms, each tested on five carefully selected receptor-binding pockets from 356 crystal complexes. Hydrogen bonds between ligands and key residues (His323, His449, Tyr473) were analyzed at various hydrogen-bond displacement (HBD) thresholds (6-12 Å). The LDR was calculated as the percentage of the top 20-scoring poses that lacked hydrogen bonds. We found that adding constraints on pose diversity and allowing receptor flexibility can improve LDR's ability to distinguish full from partial agonists. Finally, MODO-sampling-based LDR calculations were conducted on 1079 ChEMBL ligands (393 full agonists and 686 partial agonists). In this validation set, LDR successfully differentiated partial from full agonists (t-test, p = 0.00043) using the genetic algorithm with the 3B1M-KRC binding pocket and a 10 Å hydrogen-bond threshold. In QSAR applications for drug discovery, we have developed a dynamics-aware molecular descriptor, LDR, that can be a key factor in quantifying partial agonism arising from small-molecule ligand drift away from the primary orthosteric site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.